Robert Lutz

Consultor / Asesor en

ShangPharma Innovation, Inc.

Consumer Services

Health Technology

Finance

Perfil

Robert Lutz is currently an Executive-in-Residence at ShangPharma Innovation, Inc. He was previously a VP-Translational Research & Development at ImmunoGen, Inc. from 1992 to 2015.
He received a doctorate degree from Brandeis University in 1987 and an undergraduate degree from the University of New Hampshire in 1981.

Cargos activos de Robert Lutz

Empresas	Cargo	Inicio
ShangPharma Innovation, Inc. ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements.	Consultor / Asesor	-

Todos los cargos activos de Robert Lutz

Antiguos cargos conocidos de Robert Lutz.

Empresas	Cargo	Fin
IMMUNOGEN, INC.	Corporate Officer/Principal	01/04/2015

Ver el detalle de la experiencia de Robert Lutz.

Formación de Robert Lutz.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Robert Lutz.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics	Health Technology
Brandeis University Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of New Hampshire University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ShangPharma Innovation, Inc. ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements.	Finance